These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31583613)

  • 1. A Preterm Physiologically Based Pharmacokinetic Model. Part I: Physiological Parameters and Model Building.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):485-500. PubMed ID: 31583613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preterm Physiologically Based Pharmacokinetic Model. Part II: Applications of the Model to Predict Drug Pharmacokinetics in the Preterm Population.
    Abduljalil K; Pan X; Pansari A; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 Apr; 59(4):501-518. PubMed ID: 31587145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of maternal pharmacokinetics using physiologically based pharmacokinetic models: assessing the impact of the longitudinal changes in the activity of CYP1A2, CYP2D6 and CYP3A4 enzymes during pregnancy.
    Abduljalil K; Pansari A; Jamei M
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):361-383. PubMed ID: 32840724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation and validation of ontogeny functions for cytochrome P450 1A2 and 3A4 based on in vivo data.
    Salem F; Johnson TN; Abduljalil K; Tucker GT; Rostami-Hodjegan A
    Clin Pharmacokinet; 2014 Jul; 53(7):625-36. PubMed ID: 24671884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.
    Abduljalil K; Jamei M; Johnson TN
    Clin Pharmacokinet; 2019 Feb; 58(2):235-262. PubMed ID: 29987449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
    Kanamori M; Takahashi H; Echizen H
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accounting for inter-correlation between enzyme abundance: a simulation study to assess implications on global sensitivity analysis within physiologically-based pharmacokinetics.
    Melillo N; Darwich AS; Magni P; Rostami-Hodjegan A
    J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):137-154. PubMed ID: 30905037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross Composition.
    Abduljalil K; Johnson TN; Rostami-Hodjegan A
    Clin Pharmacokinet; 2018 Sep; 57(9):1149-1171. PubMed ID: 29264787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA; Kim HS; Oh J; Cho JY; Yu KS; Lee J; Shin SH; Lee JA; Choi CW; Kim EK; Kim BI; Park EA
    Br J Clin Pharmacol; 2017 Jun; 83(6):1279-1286. PubMed ID: 27995649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future.
    O'Hara K; Wright IM; Schneider JJ; Jones AL; Martin JH
    Br J Clin Pharmacol; 2015 Dec; 80(6):1281-8. PubMed ID: 26256466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data.
    Claassen K; Thelen K; Coboeken K; Gaub T; Lippert J; Allegaert K; Willmann S
    Curr Pharm Des; 2015; 21(39):5688-98. PubMed ID: 26323410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of physiologically based pharmacokinetic simulations for assessing pediatric patients after accidental drug ingestion: A case study of a 1.4-year-old girl who ingested alprazolam.
    Emoto C; Shimizu M; Tanaka T; Yamazaki H
    Drug Metab Pharmacokinet; 2021 Aug; 39():100394. PubMed ID: 33992952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4.
    Bouillon-Pichault M; Jullien V; Bazzoli C; Pons G; Tod M
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):25-40. PubMed ID: 21046208
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zhang N; Liu J; Chen Z; Dou W
    Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro inhibitory effects of pristimerin on human liver cytochrome P450 enzymes.
    Hao X; Yuan J; Xu Y; Wang Z; Hou J; Hu T
    Xenobiotica; 2018 Dec; 48(12):1185-1191. PubMed ID: 28385095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.
    Brussee JM; Vet NJ; Krekels EHJ; Valkenburg AJ; Jacqz-Aigrain E; van Gerven JMA; Swart EL; van den Anker JN; Tibboel D; de Hoog M; de Wildt SN; Knibbe CAJ
    Br J Clin Pharmacol; 2018 Feb; 84(2):358-368. PubMed ID: 29072785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokinetics.
    Emoto C; Johnson TN
    Adv Pharmacol; 2022; 95():365-391. PubMed ID: 35953161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on Fetal Blood Components and Binding Proteins.
    Abduljalil K; Jamei M; Johnson TN
    Clin Pharmacokinet; 2020 May; 59(5):629-642. PubMed ID: 31696406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.